KORU Medical Systems, Inc.
HealthcareNASDAQ:KRMD · NASDAQ Capital Market
+$0.00 today
Vol 0.09M · Avg 0.14M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-15.5%
avg -11.8%
ROIC
-14.5%
avg -8.8%
ROA
-9.4%
avg -7.9%
Analysis
ROA is currently the strongest return metric at -9.4% versus its period average of -7.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Linda Tharby | CEO & Director | $891,440.00 | — | 58 | $620,622.00 | 1.35% |
Thomas Adams | Chief Financial Officer, Secretary & Treasurer | $582,838.00 | — | 53 | $316,340.00 | 0.69% |
Eric Schiller | Chief Technology Officer | $371,157.00 | — | 52 | $5,000.00 | 0.01% |
Adam Kalbermatten | President & Chief Commercial Officer | $170,100.00 | — | 42 | $67,779.00 | 0.15% |
Christopher Pazdan | Chief Operating Officer | — | — | 43 | $308,988.00 | 0.67% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
6
$1.48M
Sells
0
$0.00
Net Sentiment
+$1.48M
Net buying
Most Active
Tharby Linda M
2 transactions
Analysis
Insiders reported 6 buys worth $1.48M and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $1.48M. Tharby Linda M was the most active insider with 2 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +0.0% | +13.2% (13yr)1 analysts |
| Revenue | N/A | N/A | +16.4% | +13.6% (13yr)1 analysts |
| Net Income | N/A | N/A | +2.6% | +14.6% (13yr)1 analysts |
| EBIT | N/A | N/A | +3.6% | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +16.4% over three years. Forward estimates point to Net Income at +14.6% (13yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Prenetics Global Limited
NASDAQ:PRE
$367.72M
OraSure Technologies, Inc.
NASDAQ:OSUR
$287.79M
Utah Medical Products, Inc.
NASDAQ:UTMD
$216.00M
Profound Medical Corp.
NASDAQ:PROF
$200.47M
InfuSystem Holdings, Inc.
AMEX:INFU
$184.46M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$142.92M
MaxCyte, Inc.
NASDAQ:MXCT
$119.98M
Neuronetics, Inc.
NASDAQ:STIM
$92.55M
Nyxoah S.A.
NASDAQ:NYXH
$55.05M
Vyome Holdings, Inc.
HIND
$12.95M
Who manages KRMD?
KORU Medical Systems, Inc. (KRMD) lists 5 active executives. The top listed executive is Linda Tharby, CEO & Director.
Are KRMD insiders buying or selling?
Recent insider activity shows net buying of $8.75M.
Explore More
Continue the stock analysis
Jump to another research area for this company.